Financial statements Tar-Drog Spółka Z Ograniczoną Odpowiedzialnością
Balance sheet data of TAR-DROG SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|---|---|
Total assets | 2 176 671,40 | 1 551 745,62 | 2 154 936,70 | 1 825 075,76 | 2 282 193,53 | 3 031 266,02 |
A. Fixed assets | 9 142,93 | 105 972,86 | 155 859,50 | 78 492,59 | 52 734,31 | 108 153,10 |
B. Current assets | 2 167 528,47 | 1 445 772,76 | 1 999 077,20 | 1 746 583,17 | 2 229 459,22 | 2 923 112,92 |
C. Share capital contributions (basic funds) | - | - | - | - | - | - |
D. Own shares (stocks) | - | - | - | - | - | - |
Total liabilities | 2 176 671,40 | 1 551 745,62 | 2 154 936,70 | 1 825 075,76 | 2 282 193,53 | 3 031 266,02 |
A. Equity | 1 626 607,47 | 813 406,42 | 1 215 234,69 | 1 049 785,57 | 1 067 756,84 | 2 484 637,70 |
B. Liabilities and provisions for liabilities | 550 063,93 | 738 339,20 | 939 702,01 | 775 290,19 | 1 214 436,69 | 546 628,32 |
I. Long-term liabilities | - | - | - | - | - | - |
II. Short-term liabilities | 550 063,93 | 738 339,20 | 939 702,01 | 775 290,19 | 1 214 436,69 | 546 628,32 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.